Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking approach to diabetes management. These innovative medications operate by mimicking the inherent actions of GLP-1, a hormone secreted by the https://safiyapaqw143722.blogsumer.com/38012891/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes